rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2006-12-20
|
pubmed:abstractText |
Given the controversy regarding the use of droperidol and the high cost of the 5-HT3 antagonists, a cost-effective alternative for routine use as a prophylactic antiemetic would be desirable. We designed two parallel, randomized, double-blind sham and placebo-controlled studies to compare the early and late antiemetic efficacy and adverse event profile of transdermal scopolamine (TDS) 1.5 mg, to ondansetron 4 mg IV, and droperidol 1.25 mg IV for antiemetic prophylaxis as part of a multimodal regimen in "at risk" surgical populations.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1526-7598
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
104
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
92-6
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:17179250-Adjuvants, Anesthesia,
pubmed-meshheading:17179250-Administration, Cutaneous,
pubmed-meshheading:17179250-Adolescent,
pubmed-meshheading:17179250-Adult,
pubmed-meshheading:17179250-Aged,
pubmed-meshheading:17179250-Antiemetics,
pubmed-meshheading:17179250-Bariatric Surgery,
pubmed-meshheading:17179250-Double-Blind Method,
pubmed-meshheading:17179250-Droperidol,
pubmed-meshheading:17179250-Humans,
pubmed-meshheading:17179250-Laparoscopy,
pubmed-meshheading:17179250-Mammaplasty,
pubmed-meshheading:17179250-Middle Aged,
pubmed-meshheading:17179250-Ondansetron,
pubmed-meshheading:17179250-Postoperative Nausea and Vomiting,
pubmed-meshheading:17179250-Reconstructive Surgical Procedures,
pubmed-meshheading:17179250-Scopolamine Hydrobromide
|
pubmed:year |
2007
|
pubmed:articleTitle |
Transdermal scopolamine: an alternative to ondansetron and droperidol for the prevention of postoperative and postdischarge emetic symptoms.
|
pubmed:affiliation |
Department of Anesthesiology and Pain Management, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390-9068, USA. paul.white@utsouthwestern.edu
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|